Norges Bank Investment Management »

Keros Therapeutics shares owned by Norges Bank Investment Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Norges Bank Investment Management from 13F filings

Historical chart of Norges Bank Investment Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Norges Bank Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Norges Bank Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 36k 39.76
2021-09-30 $2.1M 53k 39.56

More positions owned by Norges Bank Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Ubs Group SHS (UBS)
Mastercard Incorporated Cl A (MA)
Home Depot (HD)

View all positions for Norges Bank Investment Management

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics